Literature DB >> 11120891

Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.

H Nakagawa1, R B Chadwick, P Peltomaki, C Plass, Y Nakamura, A de La Chapelle.   

Abstract

We hypothesize that loss of imprinting (LOI) of the insulin-like growth factor II (IGF2) gene is associated with a predisposition to sporadic colorectal cancer. We confirmed a previously known strong correlation between LOI and microsatellite instability and showed that LOI was not a consequence of microsatellite instability or mismatch repair deficiency. LOI of IGF2 correlated strongly with biallelic hypermethylation of a core of five CpG sites in the insulator region of IGF2/H19, which is a known CTCF-binding element. As this methylation-dependent LOI was present in both tumors and normal colonic mucosa, it is possible that hypermethylation creates a field defect predisposing to cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120891      PMCID: PMC14632          DOI: 10.1073/pnas.98.2.591

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  From gels to chips: "minisequencing" primer extension for analysis of point mutations and single nucleotide polymorphisms.

Authors:  A C Syvänen
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

2.  Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.

Authors:  G Deng; A Chen; J Hong; H S Chae; Y S Kim
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

3.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.

Authors:  O Ogawa; M R Eccles; J Szeto; L A McNoe; K Yun; M A Maw; P J Smith; A E Reeve
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

5.  Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.

Authors:  H Cui; I L Horon; R Ohlsson; S R Hamilton; A P Feinberg
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

6.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

Authors:  J M Cunningham; E R Christensen; D J Tester; C Y Kim; P C Roche; L J Burgart; S N Thibodeau
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

7.  Aging and DNA methylation in colorectal mucosa and cancer.

Authors:  N Ahuja; Q Li; A L Mohan; S B Baylin; J P Issa
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

8.  Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2.

Authors:  J L Thorvaldsen; K L Duran; M S Bartolomei
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

9.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

Authors:  M L Veigl; L Kasturi; J Olechnowicz; A H Ma; J D Lutterbaugh; S Periyasamy; G M Li; J Drummond; P L Modrich; W D Sedwick; S D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome.

Authors:  R Ohlsson; A Nyström; S Pfeifer-Ohlsson; V Töhönen; F Hedborg; P Schofield; F Flam; T J Ekström
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

View more
  72 in total

1.  Cancer epigenetics takes center stage.

Authors:  A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy.

Authors:  Cathrine Hoyo; Amy P Murtha; Joellen M Schildkraut; Randy L Jirtle; Wendy Demark-Wahnefried; Michele R Forman; Edwin S Iversen; Joanne Kurtzberg; Francine Overcash; Zhiqing Huang; Susan K Murphy
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

Review 3.  Pathogenesis and consequences of uniparental disomy in cancer.

Authors:  Hideki Makishima; Jaroslaw P Maciejewski
Journal:  Clin Cancer Res       Date:  2011-04-25       Impact factor: 12.531

4.  Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways.

Authors:  Matthew L Silviera; Brian P Smith; Jasmine Powell; Carmen Sapienza
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-01

5.  Genetic variation in insulin pathway genes and distal colorectal adenoma risk.

Authors:  A Joan Levine; Ugonna Ihenacho; Won Lee; Jane C Figueiredo; David J Vandenberg; Christopher K Edlund; Brian D Davis; Mariana C Stern; Robert W Haile
Journal:  Int J Colorectal Dis       Date:  2012-05-30       Impact factor: 2.571

6.  High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.

Authors:  Marija Balic; Martin Pichler; Jasmin Strutz; Ellen Heitzer; Christoph Ausch; Hellmut Samonigg; Richard J Cote; Nadia Dandachi
Journal:  J Mol Diagn       Date:  2009-01-29       Impact factor: 5.568

7.  Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.

Authors:  Dirk Prawitt; Thorsten Enklaar; Barbara Gärtner-Rupprecht; Christian Spangenberg; Monika Oswald; Ekkehart Lausch; Peter Schmidtke; Dirk Reutzel; Stephan Fees; Rob Lucito; Maria Korzon; Izabela Brozek; Janusz Limon; David E Housman; Jerry Pelletier; Bernhard Zabel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 8.  Mechanisms by which IGF-I may promote cancer.

Authors:  Adda Grimberg
Journal:  Cancer Biol Ther       Date:  2003 Nov-Dec       Impact factor: 4.742

9.  Validation of methylation biomarkers that distinguish normal colon mucosa of cancer patients from normal colon mucosa of patients without cancer.

Authors:  Matteo Cesaroni; Jasmine Powell; Carmen Sapienza
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-07

10.  A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.

Authors:  Xiaoming Yao; Ji-Fan Hu; Mark Daniels; Hadas Shiran; Xiangjun Zhou; Huifan Yan; Hongqi Lu; Zhilan Zeng; Qingxue Wang; Tao Li; Andrew R Hoffman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.